They can also help to improve skin health, increase strength and endurance, and enhance cognitive function
In SURMOUNT-4 (Aronne et al., *JAMA* 2024), all patients ran an open-label phase reaching maximum tolerated dose (10 mg or 15 mg weekly) for 36 weeks, losing an average of 20.9% of body weight in that phase
Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs Glibenclamide monotherapy in Japanese patients with type 2 diabetes
Mitochondrial diseases: from molecular mechanisms to therapeutic advances
I discuss the role of iodine, selenium, and salt for thyroid health, and how specific exercise protocols, amino acids and temperature can dramatically shift levels of growth hormone release in waking and in sleep
Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line